HRT Financial’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.86M Buy
497,543
+157,634
+46% +$2.38M 0.03% 811
2025
Q4
$6.13M Buy
339,909
+115,045
+51% +$2.07M 0.03% 684
2025
Q3
$4.17M Buy
224,864
+7,504
+3% +$118K 0.02% 761
2025
Q2
$3.48M Buy
217,360
+102,520
+89% +$1.83M 0.02% 690
2025
Q1
$2.23M Sell
114,840
-78,384
-41% -$1.65M 0.02% 767
2024
Q4
$4.26M Sell
193,224
-54,372
-22% -$1.05M 0.03% 444
2024
Q3
$4.17M Sell
247,596
-70,358
-22% -$1.04M 0.02% 553
2024
Q2
$3.8M Buy
317,954
+22,231
+8% +$248K 0.02% 483
2024
Q1
$3.28M Buy
295,723
+110,813
+60% +$1.13M 0.02% 390
2023
Q4
$1.6M Buy
184,910
+116,028
+168% +$902K 0.01% 760
2023
Q3
$526K Buy
+68,882
New +$517K 0.01% 1382

Other funds holding CLBT